Rasmus Friis

7PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersMechanobiologyRadiation therapyMedical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 12, 2026
Implementation of an ePRO-based system supporting treatment readiness assessments in lung cancer care: a mixed-methods study.

|Oct 19, 2025
Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF-mutant metastatic melanoma: a real-world propensity score-matched survival analysis.

Yago Garitaonaindia, Shawez Khan, Rasmus Friis

|Oct 02, 2025
Patient reported respiratory symptoms and lung radiation doses 11 years after loco-regional breast cancer radiation therapy in the DBCG RT Nation Study.

Maja Bendtsen Sharma, Lasse Hindhede Refsgaard, Elisabeth Bendstrup

|Apr 14, 2025
Cardiotoxicity in patients with metastatic melanoma treated with BRAF/MEK inhibitors: a real-world analysis of incidence, risk factors, and reversibility.

Jonas K Oddershede, Ida K Meklenborg, Lars Bastholt

|Dec 10, 2024
Remote Symptom Monitoring of Patients With Advanced Lung Cancer (The ProWide Study): A Randomized Controlled Trial.

Rasmus Blechingberg Friis, Helle Pappot, Niels Henrik Hjollund

|Jul 27, 2024
Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases-A Danish Real-World Cohort.

Karoline Dreyer Kattenhøj, Christine Louise Møberg, Louise Mahncke Guldbrandt

Pageof 2

Frequent Collaborators

3 joint publications

Henrik Schmidt

2 joint publications

Lars Bastholt

2 joint publications

Christina Ruhlmann

2 joint publications

Inge Marie Svane